A study in the "development of modernized susceptibility guidance for oral sulfamethoxazole-trimethoprim using pharmacometrics approaches" BAA pmwp #195
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40122C00174
- Awardee
-
Institute For Clinical Pharmacodynamics, Inc. UEI Z82HHPY83MC7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $291,142
Award facts
- Contract value 100% obligated
- $291,142.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541720 Research and Development in the Social Sciences and Humanities
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $291,142 |
About this award
This $291,142 firm fixed price prime contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to the Institute For Clinical Pharmacodynamics, Inc. to conduct research on updating susceptibility guidance for the oral antibiotics sulfamethoxazole-trimethoprim. The contract supports the agency's efforts to develop modernized susceptibility guidance using pharmacometric approaches. No set-aside designation was used for this award. The Institute For Clinical Pharmacodynamics, Inc. is a for-profit organization that provides pharmacometric analysis, modeling, research, and other scientific services to federal agencies, primarily the Department of Health and Human Services FDA, focused on reducing the risk of developing antimicrobials.
Quick answers
Who was awarded contract 75F40122C00174?
75F40122C00174 was awarded to Institute For Clinical Pharmacodynamics, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 22, 2022.
How much is contract 75F40122C00174 worth?
The government has obligated $291,142 on 75F40122C00174.
Was contract 75F40122C00174 competed?
The extent of competition for 75F40122C00174 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award